Exposure-Response Analysis of Efsubaglutide Alfa in Patients with Type 2 Diabetes Mellitus.
Saved in:
| Title: | Exposure-Response Analysis of Efsubaglutide Alfa in Patients with Type 2 Diabetes Mellitus. |
|---|---|
| Authors: | Wang Q; Innogen Pharmaceutical Technology Co., Ltd., No. 501, Building 10, 299 Bi Bo Road, Shanghai, 201203, China. qh_wang@fudan.edu.cn.; Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, 200040, China. qh_wang@fudan.edu.cn., Jiang F; Innogen Pharmaceutical Technology Co., Ltd., No. 501, Building 10, 299 Bi Bo Road, Shanghai, 201203, China., Xu Y; Innogen Pharmaceutical Technology Co., Ltd., No. 501, Building 10, 299 Bi Bo Road, Shanghai, 201203, China., Lei Y; Innogen Pharmaceutical Technology Co., Ltd., No. 501, Building 10, 299 Bi Bo Road, Shanghai, 201203, China., Zhang L; Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, 200040, China., Sun X; Department of Endocrinology and Metabolism, Affiliated Hospital of Shandong Second Medical University, Weifang, 261031, China. |
| Source: | Clinical pharmacokinetics [Clin Pharmacokinet] 2025 Dec; Vol. 64 (12), pp. 1785-1797. Date of Electronic Publication: 2025 Oct 17. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: Adis, part of Springer Science+Business Media Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1179-1926 |
|---|---|
| DOI: | 10.1007/s40262-025-01570-9 |
